立即開始
AlenCiken

CLBS granted regenerative medicine advanced therapy by FDA

看多
AlenCiken  
NASDAQ:CLBS   None
Trend Analysis Chart Patterns Technical Indicators
2
0
trendanalysis chartpattern indicator
Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina

www.caladrius.com/pr...g-refractory-angina/
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。